These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34902212)

  • 1. Indomethacin Polymorph δ Revealed To Be Two Plastically Bendable Crystal Forms by 3D Electron Diffraction: Correcting a 47-Year-Old Misunderstanding.
    Lightowler M; Li S; Ou X; Zou X; Lu M; Xu H
    Angew Chem Int Ed Engl; 2022 Feb; 61(7):e202114985. PubMed ID: 34902212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer templating of supercooled indomethacin for polymorph selection.
    McKellar SC; Urquhart AJ; Lamprou DA; Florence AJ
    ACS Comb Sci; 2012 Mar; 14(3):155-9. PubMed ID: 22332944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct structure determination of vemurafenib polymorphism from compact spherulites using 3D electron diffraction.
    Li S; Lightowler M; Ou X; Huang S; Jiang Y; Li X; Zou X; Xu H; Lu M
    Commun Chem; 2023 Jan; 6(1):18. PubMed ID: 36697943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure determination, thermal stability and dissolution rate of δ-indomethacin.
    Andrusenko I; Hamilton V; Lanza AE; Hall CL; Mugnaioli E; Potticary J; Buanz A; Gaisford S; Piras AM; Zambito Y; Hall SR; Gemmi M
    Int J Pharm; 2021 Oct; 608():121067. PubMed ID: 34481012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic Transformation of Indomethacin during Hot Melt Extrusion Granulation: Process and Dissolution Control.
    Xu T; Nahar K; Dave R; Bates S; Morris K
    Pharm Res; 2018 May; 35(7):140. PubMed ID: 29748722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melt Crystallization of Indomethacin Polymorphs in the Presence of Poly(ethylene oxide): Selective Enrichment of the Polymer at the Crystal-Liquid Interface.
    Zhang J; Shi Q; Guo M; Liu Z; Cai T
    Mol Pharm; 2020 Jun; 17(6):2064-2071. PubMed ID: 32298128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
    Suzuki H; Iwata M; Ito M; Noguchi S
    Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity differences of indomethacin solid forms with ammonia gas.
    Chen X; Morris KR; Griesser UJ; Byrn SR; Stowell JG
    J Am Chem Soc; 2002 Dec; 124(50):15012-9. PubMed ID: 12475345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.
    Patel DD; Joguparthi V; Wang Z; Anderson BD
    J Pharm Sci; 2011 Jul; 100(7):2623-41. PubMed ID: 21259238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and solid-state characteristics of a new crystal form of indomethacin.
    Lin SY
    J Pharm Sci; 1992 Jun; 81(6):572-6. PubMed ID: 1522497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Feb; 91(2):492-507. PubMed ID: 11835208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mechanical stress in crystallization and relaxation behavior of amorphous indomethacin.
    Bhugra C; Shmeis R; Pikal MJ
    J Pharm Sci; 2008 Oct; 97(10):4446-58. PubMed ID: 18228583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry.
    Otsuka M; Kato F; Matsuda Y
    Analyst; 2001 Sep; 126(9):1578-82. PubMed ID: 11592653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of supersaturation II: indomethacin crystal growth kinetics versus degree of supersaturation.
    Patel DD; Anderson BD
    J Pharm Sci; 2013 May; 102(5):1544-53. PubMed ID: 23494835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
    Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Tabletability Differences between Indomethacin Polymorphs Using Powder Brillouin Light Scattering.
    Young BA; Bahl D; Stevens LL
    Pharm Res; 2019 Aug; 36(10):150. PubMed ID: 31428879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.